×
MPS Pharmaa

ADVIKLA

Price
Nano Cap
₹3 Cr.
Advik Laboratories Ltd focuses on achieving USFDA standards of quality with a product range including ethical drugs such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe… More
Advik Laboratories Ltd focuses on achieving USFDA standards of quality with a product range including ethical drugs such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-C; generic drugs like antibacterials, antiallergics, antifungals, analgesics, antipyretics, and anti-inflammatories; anti-hypertensives, anthelminthics, anti-malarials, corticosteroids, erectile dysfunction medications, gastrointestinal agents, and sedatives. Less
Advik Laboratories Ltd focuses on achieving USFDA standards of quality with a product range includi… More
Advik Laboratories Ltd focuses on achieving USFDA standards of quality with a product range including ethical drugs such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-C; generic drugs like antibacterials, antiallergics, antifungals, analgesics, antipyretics, and anti-inflammatories; anti-hypertensives, anthelminthics, anti-malarials, corticosteroids, erectile dysfunction medications, gastrointestinal agents, and sedatives. Less
Low
1.57
52W Range
High
3.17
PE
--
Sector PE
26.28
P/B
4.65
Div.Yield
--
ROE
--
EBIDTA
--
ROCE
-68.19
EPS
-0.12

Get instant stock alerts
  • Share Price
  • Financials
  • Revenue mix
  • Shareholdings
  • Peers
  • Forensics
Niche index constructed using market cap and revenue exposure of companies in this sector

Coming soon

  • 5D
  • 1M
  • 6M
  • YTD
  • 1Y
  • 5Y
  • MAX

  • Summary

  • Profit & Loss

  • Balance sheet

  • Cashflow

Yearly | Quarterly
View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly
(In Cr.)
(In Cr.)

This data is currently unavailable for this company.
Financial Ratio's
(In %)
Detailed P&L Report Detailed P&L Report
(In Cr.)
Detailed Balance Sheet
Financial Year (In Cr.)
Detailed Cash Flow

  • Product wise

  • Location wise

ADVIKLA
Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    ADVIKLA
    Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    More Info

    Shareholdings

    Holders
    Detailed Shareholdings

    This data is currently unavailable for this company.

    Peers
    Detailed Peers

    Forensics

    View Detailed Forensics

    Recent events

    • News

    • Corporate Actions

    MPS Pharmaa Approves Retrenchment Of 10 Workers

    Mar 03, 2026

    Events:

    Announcement Date
    Feb 02, 2026
    Announcement Date
    Nov 14, 2025
    Announcement Date
    Sep 08, 2025
    Announcement Date
    Sep 05, 2025
    Announcement Date
    Aug 12, 2025
    Announcement Date
    May 28, 2025
    Announcement Date
    Feb 12, 2025
    Announcement Date
    Nov 14, 2024
    Announcement Date
    Aug 13, 2024
    Announcement Date
    Feb 13, 2024
    Announcement Date
    Nov 09, 2023
    Announcement Date
    Sep 05, 2023
    Announcement Date
    Aug 12, 2023
    Announcement Date
    May 29, 2023
    Announcement Date
    Feb 03, 2023
    Announcement Date
    Nov 12, 2022
    Announcement Date
    Sep 06, 2022
    Announcement Date
    Aug 12, 2022
    Announcement Date
    May 21, 2022
    Announcement Date
    Jan 08, 2022
    Announcement Date
    Oct 13, 2021
    Announcement Date
    Aug 04, 2021
    Announcement Date
    Jun 30, 2021
    Announcement Date
    Feb 12, 2021
    Announcement Date
    Nov 11, 2020
    Announcement Date
    Sep 09, 2020
    Announcement Date
    Jul 29, 2020
    Announcement Date
    Jun 30, 2020
    Announcement Date
    Feb 13, 2020

    More Nano Cap Ideas

    See similar 'Nano' cap companies with recent activity

    Promoter Buying

    Companies where the promoters are bullish

    Detailed List

    Capex

    Companies investing on expansion

    Detailed List

    Superstar Investor

    Companies where well known investors have invested

    Detailed List